GoldNApel FB Update!! GoldNApel 10/10/2013. Hi

New Post Public Reply Private Reply Replies (6) Message Board
on41greyst
GoldNApel FB Update!!

GoldNApel 10/10/2013.

Hi Everybody,

I have been carrying on a conversation with Chris on the facebook message feature. He recently inquired if we were still active because he hadn't heard from me for a few days, as we were quite busy. I wrote him a long reply and realized that it might be good to share it with everyone. Here it is:

Hi Chris,

Yes we are active and we have been working very hard. Sorry I was slow in replying. That time of the year! Harvest time for a strain of Cannatonic that yielded over 17% CBD several years back. Waiting for tests on this year's efforts. Hopefully we have the THC down to near nothing, but actually, it doesn't matter all that much anymore. We can now preserve all of the cannabinoids in their non-psychoactive form with the new technology that Dr. Apel has developed over the last year or so, and that we announced today.

The "game-changer" we talked about a while back is here. I really believe that our new Dharmanol preparation will enable a cancer patient to take 10 or more times the cannabinoids that are recommended in Simpson therapy, and there may well be no cancer that can stand up to this kind of treatment in an otherwise-healthy individual. Everything we have seen in this field of research indicates that this may well be true.

I will never claim a "cure" until we have some double-blind placebo-controlled tests of the type Dr. Abrams wants to do, if the government would ever give him some "official" cannabis oil to experiment with, but even a person with no formal education in science can go online, google keywords like "cannabis cancer" and do many hours of informative reading from reputable scientific sources.

I would think that anyone with an interest in what SK3 and BBio are doing would perform this simple task and see what the current research is saying. Even the staunchest skeptic, with a bit of reading and study, would likely agree that cannabinoid therapy is indeed a treatment for cancer that holds a great deal of promise for mankind. That is why I find it so hard to believe that there are those who try so hard to question everything that we are doing, and present all of our activities in the worst possible light on the message boards.

(By the way, I will scan the boards on a day such as today, but all of us are far too busy building our respective parts of this company to put much time and effort into the boards).

Several months ago I said that I would answer any questions here that I could from those who speculate on the message boards, and I appreciate your starting a conversation with me, but I have received very few questions.

The announcement today was just a part of where we see this going. We now have the capacity to remove the psychoactivity from the kind herb, and make it truly a kind medicine, for all of those in need of healing. There are several different delivery systems we are working on, as well as combinations with other healing herbs and supplements, providing Dharmanol-based medicines tailored specifically for a variety of the ailments that cannabinoid therapy has shown to be effective in treating.

Thanks again for the conversation. I will always do my best to keep a good dialogue going.

Dave

While I'm at it, let me clarify low-dose and high-dose Dharmanol. The low-dose tablets are designed for daily health maintenance with a total of 10 mg. of cannabinoids, consisting of 5 mg. CBD and 5 mg. mixed cannabinoid carboxylates (which have been stabilized in their non-psychoactive form), and an additional 5 mg of steam-extracted terpenes and terpenoids from a variety of strains of cannabis. (The terpenes help the cannabinoids bind to the receptors, enhancing the efficacy of the treatment). Also, the steam-extract allows the extraction and inclusion of many different elements of the kind herb which have demonstrated that so-called whole plant medicinals are much better than just the isolated elements, in many cases, and utilizing an extract from the widest variety of strains possible insures that we get some of the entire spectrum of whole-plant goodness.

The purpose of high-dose Dharmanol is to provide the body of a cancer patient with the equivalent of a Simpson dose, but without the psychoactivity or "high". A different delivery system is being prepared for utilizing Dharmanol in high doses for the treatment of serious illnesses, but it is not inconceivable for a person treating cancer to chew 8 low-dose Dharmanol tablets six times a day, which would give a Simpson-sized dose with no side effects, and, in strictly my own opinion, the safest and most promising experimental cancer treatment that is currently being studied in the world of cannabis science.

The ultimate hope for Dharmanol will come in mega-doses that exceed the Simpson norm many times. Simpson's recommended dose is about one ten-thousandth of the LD-50 for marijuana. (LD-50 is the amount of a drug that will kill half of the lab animals to which it is administered). Most cancer drugs are so harmful to the body that the effective dose is a large percentage of the size dose that will cause death.

With the huge ratio between the Simpson dose and the LD-50 for cannabis, there is opportunity to step up the dosage levels many times. The only reason this isn't done is because handling a full gram of strong cannabis oil daily is very difficult for many people, especially by those who have never experienced cannabis. Now that we have removed the psychoactivity and medicinalized the plant, we will soon see the results of people treating serious illnesses with many times the doses possible today.

Cannabis medicine works on both ends of the spectrum. Small daily doses will tune up the body's own endo-cannabinoid system, keeping one healthy. Large doses are doseage-dependent, meaning the more the better. University lab tests have shown that concentrated cannabis medicine, when applied to cancerous tissue, adjacent to healthy tissue, will directly kill the malignant cells, while simultaneously strengthening the healthy ones. Even though there are many other mechanisms that cannabis uses to fight disease, I find this one amazing, and indicative of the special energy that this wonderful plant holds.

Thanks!

Dave

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Massimo Debuts 1500 UTV Line at 2026 SEMA Show

Updated Category News Views 110

Setting the Stage at SEMA 2026 In the chaotic whirl of the 2026 SEMA Show, Massimo Group didn't just roll out new wheels—they took a leap into the big leagues. Amidst the bustling Vegas crowd, Massimo unveiled their latest babies: the Warrior 1500XD and the Sentinel 1500 HVAC Crew. These ain't just any UTVs; they're packing some serious muscle with a 1,499cc engine,...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 92

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
Metacon Q3 Report Unveiled Amid Green Hydrogen Buzz

Updated Category News Views 43

Peeling Back Metacon's Q3 2026 Figures Alright, let's sink our teeth into the meat and potatoes of Metacon's latest report. The interim report for Q3 2026 hit the newsstands, but it's what's lurking behind the numbers that tells the real story. With all the green energy buzz, Metacon's report is a mixed bag, reflecting their uphill journey in hydrogen pursuits and...

Continue Reading
PrimeBOT: Breaking Tech Molds with Celeb Backing

Updated Category News Views 62

Not Your Average Tech Buzz It starts with Hollywood glitz and an unexpected dance partner. The PrimeBOT, a Chinese personal robot, is ditching the drab tech corner and seeping into mainstream culture. Imagine Johnny Depp slapping some paint on this machine alongside local kids. Now, picture the Kardashians casually dining with it, letting it join their lunchtime...

Continue Reading
ISU and Ares Forge Path in Solid-State Battery Tech

Updated Category News Views 76

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Continue Reading
SRG DocketWatch: Tracking FCC Docs in Real-Time

Updated Category News Views 48

I'll admit it—sometimes the FCC moves like molasses uphill. But keeping track of what they're up to? That's where the real challenge lies. Summit Ridge Group has tossed a lifeline for anyone who's got skin in the game with their new service, SRG DocketWatch. Why SRG DocketWatch Hits the Mark If you're poking your head into more than a few of those 21,000 FCC...

Continue Reading
Doximity Faces Class Action: Investor Guidance Needed

Updated Category News Views 54

Doximity Lands in Hot Water: The Stakes for Investors Alright, traders, there's a storm brewing around Doximity (NYSE:DOCS), and it's a doozy. A class action lawsuit has been slapped on this digital platform for medical pros, and the accusations are serious. If you rode the wave and snagged yourself some shares between August 8, 2024, and May 13, 2026, you're right in the...

Continue Reading
Sectra Powers Radiology at Mount Sinai with AI Integration

Updated Category News Views 31

AI and Radiology: A Match Made for Mount Sinai Today, we're diving into a technological leap that promises to shake up the healthcare sector—Sectra's integration of artificial intelligence with radiology at Mount Sinai Health System. The deal pairs Sectra's prowess in medical imaging IT and cybersecurity with the healthcare giant in New York, aiming to redefine how...

Continue Reading
Protein Dynamics: Insights into DNA Maintenance

Updated Category News Views 28

Unlocking the Mechanics of DNA Handling If there's one thing that drives scientific snooping, it's the quest for details as minute as a fly speck on an elephant. Over at Kanazawa University, scientists have peeled back the curtain on an intriguing game of molecular ballet. What they've used to catch this dance in action? High-speed atomic force microscopy, that’s what....

Continue Reading
IGT and MGM Springfield Unveil Jackpot Games in MA

Updated Category News Views 101

Milestone Event in Massachusetts Gaming Scene When IGT and MGM Springfield team up to unveil the first wide-area progressive slots games in Massachusetts, it’s more than just a new game on the floor—it's a seismic shift in the region's gambling landscape. We've got twenty new shiny wheels turning over at the MGM Springfield, with jackpots starting at a hefty $1.125...

Continue Reading

Top 5 Most Recently Viewed Articles

Unveiling the Growth of a $100 Mastercard Investment Over 15 Years

Updated Category News Views 135

Understanding Mastercard's Remarkable Growth Mastercard Inc (NYSE: MA) has shown impressive performance in the financial market, consistently outpacing the overall market by a remarkable margin. Over the past 15 years, the company has achieved an average annual return of 25.57%. This exceptional performance is indicative of the strong fundamentals and strategic business...

Continue Reading
A Deep Dive into Comcast's Position Against Media Rivals

Updated Category News Views 74

Decoding Comcast's Market Strategy In the frenetic whirl of the media industry, you’ve got to keep your head on a swivel—there’s competition at every corner. Comcast (CMCSA) finds itself in this digital gladiatorial arena, vying for attention against other big shots while riding on some impressive wins from previous acquisitions. Operating through three robust...

Continue Reading
U.S. Renal Care Celebrates Back-to-Back Workplace Honors

Updated Category News Views 150

U.S. Renal Care's Achievement in Workplace Excellence In a significant accomplishment for U.S. Renal Care, the company has been honored once again by Newsweek as one of America's Greatest Workplaces. This recognition highlights the organization’s dedication to creating an empowering and supportive environment for its employees, particularly in the healthcare sector. For...

Continue Reading
Unveiling the Finalists of the ServiceTitan Elite Trades Championship

Updated Category News Views 260

ServiceTitan Elite Trades Championship Series Finalists Announced The highly anticipated ServiceTitan Elite Trades Championship Series (ETCS) is ready to unveil the talented individuals who will compete in the upcoming finals. These competitors have worked hard to secure their places and are set to demonstrate their skills, precision, and expertise in the trades sector....

Continue Reading
Bekaert's Successful Share Buyback and Liquidity Update

Updated Category News Views 282

Update on Bekaert's Latest Share Buyback Program In an exciting development, Bekaert has announced significant progress regarding its share buyback program. They have allocated a maximum budget of €25 million for the current tranche, a strategic decision that's aimed at retiring shares in circulation to enhance value for shareholders. Recent Share Acquisition Details...

Continue Reading